Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cell Death & Disease|October 20, 2017
CD10<sup>-</sup>/ALDH<sup>-</sup> cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchyBrendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trialMarie Plante, Sven Mahner, Alexandra Sebastianelli, et al.
International Journal of Molecular Sciences|January 24, 2013
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screeningAlexandros Laios, Bashir M Mohamed, Lynn Kelly, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical HysterectomySarah E Ferguson, Lori A Brotto, Janice Kwon, et al.
Journal of Gynecologic Oncology|October 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trialJanice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Ebiomedicine|April 7, 2019
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcomeSuzy Scholl, Marina Popovic, Anne de la Rochefordiere, et al.
Pageof 4